Zofran Name
Ondansetron
Zofran Class
Antiemetic agent
Zofran MOA
Selectively blocks serotonin 5-HT receptors located in the CNS at the chemoreceptor trigger zone and in the peripheral nervous system on nerve terminals of the vagus nerve
Zofran Indications
Nausea and vomiting
Zofran Contraindications
Zofran Adverse Reactions
CNS: Headache, malaise, fatigue, dizziness, fever, sedation, extrapyramidal syndrome
CV: chest pain, arrhythmias
Resp: hypoxia
GI/hepatic: Diarrhea, constipation, abdominal pain, xerostomia, decreased appetite
Skin: rash
Zofran Incompatibilities/Drug Interactions
Inducers or inhibitors of P450 drug metabolizing enzymes may alter the clearance of Ondansetron. No dosage adjustment is recommended.
Zofran Adult Dosage
4-8mg IV slow push over 2-5 minutes
8mg PO ODT or tablet
Zofran Pediatric Dosage (1month to 12 years)
Greater than 40 kg- 4 mg IV slow push over 2 – 5 minutes
Less than 40 kg- 0.1 mg/kg IV slow push over 2 – 5 minutes
4-12 years old 4 mg PO ODT
Zofran Routes of Administration
IV, IM, PO
Zofran Onset
Unknown, probably 10-30 minutes
Zofran Peak Effects
Unknown
Zofran Duration
Half life approximately 4 hours
Zofran AZ Drug Box Minimum
Optional 4mg